from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0222/echA1

LFCtreatmentdescriptionclass of inhibitor

-0.112

Amikacinug/mL Amikacintranslation

-1.512

Cap5-10ug/mL Capreomycintranslation

-1.190

Rox10-50 ug/mL Roxithromycintranslation

0.061

SM2-5 ug/mL Streptomycintranslation

0.092

Tet5-10 ug/mL Tetracyclinetranslation

1.192

Rif0.2-5ug/mL Rifampicintranscription

-0.219

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.806

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.419

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.992

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.968

Clofazimine10-13 ug/mL Clofaziminerespiration

0.673

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.596

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.482

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.257

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.537

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.543

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.753

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.429

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.338

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.609

KCN5-20 ug/mL Potassium cyaniderespiration

-0.487

NaN30.2-2 mM Sodium aziderespiration

0.091

Nigericin50 uM Nigericinrespiration

-0.333

TRC10-150 ug/mL Triclosanrespiration

-1.697

TRZ10-25 ug/mL Thioridazinerespiration

-2.753

Valinomycin0.5-10 uM Valinomycinrespiration

0.049

ZnSO42 mM ZnSO4respiration

-0.452

menadione6-10 ug/mL Menadionerespiration

-0.260

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.191

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.416

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.012

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.273

NRP_1Non-replicating persistence stage 1dosRassociated

-0.486

Amp0.2mg/mL AmpicillincellWall

0.081

Cephalexin20-100 ug/mL CephalexincellWall

0.256

Cerulenin0.32-5 ug/mL CerulenincellWall

0.861

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.506

EMB10-20 ug/mL EthambutolcellWall

0.397

Eta12-40 ug/mL EthionamidecellWall

0.718

INH0.2-0.4 ug/mL IsoniazidcellWall

0.166

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.554

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.440

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.021

BZA0.12 mg/mL BenzamidearomaticAmides

0.406

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.331

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.787

H2O24 mM hydrogen peroxideDNAdamaging

0.053

Levo10 ug/mL LevofloxacinDNAdamaging

0.577

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.915

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.266

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.554

UVUV-irradiationDNAdamaging

-1.148

ARP41-4 ug/mL Antitubercular compound ARP4?

0.458

Antimycin12.5-50 ug/mL Antimycin A?

-0.038

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.478

PA_110-50 ug/mL Antitubercular compound PA-1?

0.192

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.156

PA8240.2-2 ug/mL PA-824?

-0.935

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.068

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.693

Verapamil50 uM Verapamil?

-0.145

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.013

methoxatin10-20 ug/mL Methoxatin?